4.5 Article

Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2

Related references

Note: Only part of the references are listed.
Article Immunology

Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study

Dana Danino et al.

Summary: During the COVID-19 pandemic in Israel, reductions in pneumococcal and pneumococcus-associated diseases were strongly associated with the disappearance of specific respiratory viruses, rather than reduced pneumococcal carriage and density.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021

Stephanie Perniciaro et al.

Summary: The incidence of invasive pneumococcal disease (IPD) in Germany showed a declining trend in 2020-2021 under the influence of nonpharmaceutical interventions (NPIs), but exhibited variations in age and serotype specificity over time.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Infant Pneumococcal Carriage in Belgium Not Affected by COVID-19 Containment Measures

Laura Willen et al.

Summary: Streptococcus pneumoniae, a common respiratory pathogen, can cause serious diseases when carried in the nasopharynx. The COVID-19 pandemic and restrictive measures have led to a significant decrease in invasive diseases caused by respiratory bacteria. However, a study found that the carriage rate of pneumococci remained high during this period, suggesting a possible connection between the nasopharyngeal microbiome and pneumococcal invasion.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Multidisciplinary Sciences

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

John-Sebastian Eden et al.

Summary: Non-pharmaceutical interventions and travel restrictions for COVID-19 have impacted the circulation of respiratory viruses, including RSV. This study reports the resurgence of RSV in Australia following the lifting of some restrictions, and describes a reduction in genetic diversity in circulating RSV clades.

NATURE COMMUNICATIONS (2022)

Article Medicine, General & Internal

Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France

Alexis Rybak et al.

Summary: This study examined the impact of nonpharmaceutical interventions implemented during the COVID-19 pandemic on the incidence of invasive pneumococcal disease (IPD) in France. The results showed that the decrease in IPD incidence was associated with decreased viral infection cases, rather than changes in pneumococcal carriage rate.

JAMA NETWORK OPEN (2022)

Article Immunology

Impact of Coronavirus Disease 2019 Public Health Measures on Detections of Influenza and Respiratory Syncytial Virus in Children During the 2020 Australian Winter

Daniel K. Yeoh et al.

Summary: Public health measures aimed at COVID-19 have led to significant reductions in respiratory syncytial virus and influenza detections among children in Western Australia during winter 2020, despite schools reopening. Border closures are likely playing a key role in limiting external introductions of respiratory viruses.

CLINICAL INFECTIOUS DISEASES (2021)

Article Public, Environmental & Occupational Health

Routine Vaccination Coverage — Worldwide, 2020

Pierre Muhoza et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Review Infectious Diseases

Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?

Robert Cohen et al.

Summary: The COVID-19 pandemic has reduced the incidence of many viral and bacterial infections in children, leading to a positive short-term effect of preventing healthcare system overload. However, the reduced exposure to pathogens and vaccination rates may result in a potential immunity debt and increase the risk of future epidemics when non-pharmaceutical interventions are lifted.

INFECTIOUS DISEASES NOW (2021)